Vistagen CEO Shawn Singh to Join Executive Roundtable Discussing Mental Health at Concordia Annual Summit
September 20 2022 - 8:30AM
Business Wire
Goldie Hawn to lead discussion on supporting
mental health around the globe with preeminent C-suite executives,
politicians, nonprofit leaders and entrepreneurs on the importance
of mental health
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical
company aiming to transform the treatment landscape for individuals
living with anxiety, depression, and other central nervous system
(CNS) disorders, today announced that its Chief Executive Officer,
Shawn Singh, will participate in a private executive roundtable on
September 20th at the 2022 Concordia Annual Summit being held
September 19-21, 2022, in New York City.
Mr. Singh will join Academy Award winning actress and children’s
health advocate, Goldie Hawn, as well as other preeminent C-suite
executives, politicians, nonprofit leaders, and entrepreneurs in a
roundtable entitled “Finding Solutions: Supporting Mental Health
around the Globe.” Ms. Hawn is the Chief Executive Officer and
Founder of MindUP™ | The Goldie Hawn Foundation, a not-for-profit
organization founded to help children develop the knowledge and
tools they need to manage stress, regulate emotions, and face the
challenges of the 21st century with optimism, resilience, and
compassion. The private executive roundtable will take place
following Ms. Hawn’s public fireside chat focusing on bolstering
youth mental health resources in the wake of the mental health
crisis.
Mr. Singh will bring a unique perspective to the upcoming 2022
Concordia Annual Summit on how we can change the trajectory of
mental health care, eliminate stigma surrounding anxiety and
depression and expand resources for diverse communities. Earlier
this year, Mr. Singh hosted a fireside chat with the U.S. Surgeon
General, Vice Admiral Vivek H. Murthy, MD, MBA, at the 2022
Concordia Americas Summit on how the public and private sectors can
work together to advance critical mental health care
initiatives.
“I am honored to join Ms. Hawn and executive leaders in this
timely and important roundtable discussing mental health and ways
to improve the lives of those impacted by anxiety and depression,”
said Shawn Singh, Chief Executive Officer of Vistagen. “This
roundtable is another exciting opportunity to eliminate the stigma
around mental health, encourage listening to those feeling alone
and in need and discuss Vistagen’s efforts to transform mental
health care.”
Mr. Singh joins a diverse list of leaders and executives,
including First Lady, Dr. Jill Biden, and New York City Mayor, Eric
Adams, set to participate in the 2022 Concordia Annual Summit. To
attend the 2022 Concordia Annual Summit, register here.
About Vistagen
Vistagen (Nasdaq: VTGN) is a late clinical-stage, CNS-focused
biopharmaceutical company aiming to transform the treatment
landscape for individuals living with anxiety, depression and other
CNS disorders. Vistagen is advancing therapeutics with the
potential to be faster-acting, and with fewer side effects and
safety concerns, than those that are currently available. PH94B and
PH10 belong to a new class of drugs known as pherines, which are
investigational neuroactive steroid nasal sprays designed with a
novel rapid-onset mechanism of action that activates chemosensory
neurons in the nasal passages and can impact the olfactory-amygdala
neural circuits without systemic distribution or direct activity on
CNS neurons in the brain. Vistagen is passionate about transforming
mental health care and redefining what is possible in the treatment
of anxiety and depression. Connect at www.Vistagen.com.
About 2022 Concordia Annual Summit
With over a decade of experience bringing together heads of
state, leaders of the private and NGO sectors, and new and
diversified perspectives to explore tangible solutions to local and
global challenges, the 2022 Concordia Annual Summit will be the
largest convening alongside the UN General Assembly. Concordia’s
12th Annual Summit will convene the top movers and shakers of
today’s world to spark dialogue, promote collaboration, and
collectively pave the path toward a more equitable, sustainable
future. The 2022 Concordia Annual Summit will take place at the
Sheraton New York Times Square on September 19-21, 2022.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220920005506/en/
Investors: Mark Flather Vice President, Investor
Relations (650) 577-3617 mflather@vistagen.com
Media: Nate Hitchings SKDK nhitchings@skdknick.com
Vistagen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vistagen Therapeutics (NASDAQ:VTGN)
Historical Stock Chart
From Sep 2023 to Sep 2024